IL17A and small cell lung carcinoma: Figure 3D showed the enriched KEGG pathways of targets, including progesterone-mediated oocyte maturation (hsa04914), thyroid hormone signaling pathway (hsa04919), estrogen signaling pathway (hsa04915), IL-17 signaling pathway (hsa04657), small cell lung cancer (hsa05222) and prostate cancer (hsa05215).